Phio Pharmaceuticals Corp (PHIO)

[sabaidii2]

I have a long position. I have also reduced my shares, switching them for the warrants (leverage).

Do you feel the MirImmune acquisition has, according to Geert, "enhanced shareholder value"? It certainly doesn't to me. Especially considering that the resulting dilution is the reason for yet another reverse split in the next six months. Possible good test data won't be available until H2 (ie, sometime between 7/1/2017 to 12/31/2017).

Will RXI be able to pull a rabbit out of the hat before then?

Will Eliseev's dialing-for-dollars bear fruit (ie, will Big Pharma pay up for discovery/preclinical stage drugs)? To me, this seems like desperation. What's it look like to you?

As for my wit - well, I like to make the case for how things really are; not wishful hope. Don't blame me for being cynical; blame RXI. Unless you just (very) recently bought your position, you're also well underwater. So you should be likewise cynical.